Nucleic Acids & Peptides Summit at ChinaBio™ 2027

 

The Nucleic Acids & Peptides Summit at ChinaBio™ is China’s premier gathering for the nucleic acid and peptide therapeutics community, connecting domestic innovators, global partners, and regulatory experts advancing mRNA, siRNA, ASOs, RNA editing, peptides, peptide-drug conjugates, and next-generation oral peptides.

Built on the proven pedigree of RNA Leaders and TIDES, the summit brings world-class content and unparalleled networking to China’s biotech hub.

Attendees will engage directly with leading Chinese biotech companies, research institutions, CDMOs, and investors driving breakthroughs in RNA and peptide modalities, while gaining insight from NMPA experts on regulatory pathways, manufacturing requirements, and commercialization strategies specific to China’s market.

As China’s biopharma landscape rapidly advances across oligonucleotides, peptides, mRNA, genome editing, and drug delivery, this summit bridges regional innovation with global opportunity, forging the partnerships that will translate next-generation modalities from discovery to commercialization.

More Info

---

---